Clinical Trial Update: Budesonide 3x3mg/d Versus Prednisone in Active Autoimmune Hepatitis [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial comparing budesonide 3x3 mg/day with prednisone in active autoimmune hepatitis completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Hepatitis

Drugs mentioned

• Budesonide (BUDESONIDE)
• PREDNISONE (Prednisone)

Snippet

Sponsor: Dr. Falk Pharma GmbH | Conditions: Autoimmune Hepatitis | Phase 2, Phase 3 | Status: COMPLETED